| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7b72691b61448140b9a080282c2ccf0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a74935159a0a871dd85e00c138f7fe6b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-25001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2016-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccf6c1132408710a489e6be5c45c11e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_699922c0cfbdb20a39e23bdf7b6e7bc7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ced9045e5c622e4126de2bc3f984d4f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31c9d76bdeb5dafd4697e60b6364388d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcd8629f952f04f555e54db8bd06e2a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b79ac1640ef3ffe6763fd6e637ac6ae |
| publicationDate |
2018-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20180040420-A |
| titleOfInvention |
Composition for predicting of preoperative chemoradiotherapy comprising PSMB8 marker and uses thereof |
| abstract |
The present invention includes a composition for predicting radiation resistance resistance or susceptibility of a cancer cell comprising an agent for measuring PSMB8, a kit for predicting radiation resistance or susceptibility of a cancer cell comprising the composition, a PSMB8 gene or a protein level The present invention relates to a method for providing information for predicting radiation resistance resistance or susceptibility of cancer patients. The use of a composition for predicting radiation resistance or susceptibility of a cancer cell of the present invention can provide a tailored radiation therapy by predicting the responsiveness to the preoperative chemoradiotherapy of a cancer patient and improving the therapeutic effect and the side effect There is an effect that can be reduced. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021167280-A1 |
| priorityDate |
2016-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |